ICLR

SEC filing ICLR Files Amended 6-K Report for May 2026, No Financial Information Provided

5d ago

News Clinical Research Provider Icon Stock Crashes On Accounting Probe

14d ago

News ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery

14d ago

News Globally, Value funds gave back some performance in June By Investing.com - Investing.com

14d ago

News Here's Why Icon PLC (ICLR) is a Strong Momentum Stock

14d ago

News Philips' (PHG) Diagnosis & Treatment Segment Drives Growth

14d ago

News Philips (PHG) Aids Image-Guided Treatment With New Stent System

14d ago

News ICON (ICRL) Gains From Strategic Acquisitions, Innovation

14d ago

News Icon PLC (ICLR) Upgraded to Buy: Here's What You Should Know

14d ago

News Icon PLC (ICLR) Soars 4.3%: Is Further Upside Left in the Stock?

14d ago

News ICON rebounds as accounting probe concludes

33d ago

SEC filing ICLR Reports $1.7B Revenue, $0.18 EPS, +15% YoY, Restates 2023-2024 Results, $20B Backlog, Material Weaknesses Remediation

34d ago

Failures to deliver 122,469 shares failed to deliver

89d ago

News ClearBridge Global Value Improvers Strategy adds BEP and MKKGY; exits PYPL and ICLR

99d ago

News ICON rises as Cowen upgrades after recent selloff

103d ago

News FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer

103d ago

Scanner Large down move: 39.9% (2.8x normal daily movement)

108d ago

News IQVIA slides after Q4 results as earnings outlook underwhelms

116d ago

News Missed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy.

124d ago

News Trinity Street Sells $22 Million of Axalta Coating Systems Stock

125d ago

News Polen Global Growth Portfolio adds to Taiwan Semiconductor, trims stake in Oracle in Q4 2025

130d ago

News Icon Energy Corp. Announces Updates in Connection with the SEPA

131d ago

News W. LUNABELLA presenta su primer "Centro de soluciones de belleza total" en París

134d ago

News Icon Energy Corp. Announces Reverse Stock Split

147d ago

News Q3 2025 Contract Research Organization (CRO) Activity and Intel Report Featuring ICON, Astrazeneca, Akesobio, CSPPC Pharmaceutical, ImmunityBio, and Boryung

153d ago